Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin add-on to metformin in type 2 diabetes
NCT01766778Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started May 2013; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01766778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766778.